Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.66 USD | -2.76% | +2.96% | +28.84% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.84% | 2.23B | |
-3.88% | 12.32B | |
-4.76% | 8.1B | |
+9.56% | 5.87B | |
+28.39% | 5.52B | |
-6.28% | 4.29B | |
-52.84% | 3.16B | |
+12.93% | 2.72B | |
-3.08% | 2.37B | |
-4.64% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Transcript : Myriad Genetics, Inc. - Analyst/Investor Day